Discovery on Target

Discovery On Target

2023 Conference Programmes > VIEW THE EVENT IN A GLANCE. Part 1: Protein Degraders & Molecular Glides. Drug Discovery Driven by Proteomics. Small Molecules that Target RNA. Small Molecules as Cancer Targets, Part 1. Neurodegeneration Targets. GPCR-based Drug Discovery. Antibodies against Membrane Protein Targets, Part 1.

Discovery on Target (DOT), a new publication, highlights the latest advances in "hot" targets as well as technologies. It also discusses target validation strategies to discover and develop novel therapeutic agents from small molecules to biologics.

Our goal is to satisfy your research needs. Attend concurrent sessions to hear informative presentations, engage in lively discussion, and make meaningful connections with your peers. You can further customize your experience with interactive training seminars and focused short courses.
You can engage in group discussions and network with experts by participating in networking events and group discussions.

The 20th anniversary event will feature popular topics such as immunomodulation, protein degradation, and small molecules as cancer targets.

Sponsors and exhibitors can reach a targeted audience.

We offer many options, whether you want to reach the entire community of healthcare, IT, life sciences and pharmaceutical professionals at conferences, a particular topic, an individual or a high-level decision maker.
There are many ways to reach our distinguished delegates. Discover our exhibitor or sponsor packages that offer many platforms to launch new products, gain visibility, collect feedback and network.